777 related articles for article (PubMed ID: 23463198)
1. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
3. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus entry: molecular biology and clinical implications.
Barth H; Liang TJ; Baumert TF
Hepatology; 2006 Sep; 44(3):527-35. PubMed ID: 16941688
[TBL] [Abstract][Full Text] [Related]
6. Entry inhibitors: New advances in HCV treatment.
Qian XJ; Zhu YZ; Zhao P; Qi ZT
Emerg Microbes Infect; 2016 Jan; 5(1):e3. PubMed ID: 26733381
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of cell infection with hepatitis C virus (HCV)--a new paradigm in virus-cell interaction.
Budkowska A
Pol J Microbiol; 2009; 58(2):93-8. PubMed ID: 19824391
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus entry: role of host and viral factors.
Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
[TBL] [Abstract][Full Text] [Related]
9. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
10. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
11. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
12. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
13. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
14. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
15. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
Colpitts CC; Tsai PL; Zeisel MB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197477
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
18. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
19. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
[TBL] [Abstract][Full Text] [Related]
20. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]